Devyser is specialized in the development, manufacture and sales of diagnostic kits for complex DNA testing within oncology, hereditary diseases and transplantation. The products are used to guide targeted cancer therapies, to enable a wide array of genetic tests, as well as in post-transplant follow-up. Devyser’s product development focuses on simplifying and streamlining complex testing processes to improve throughput, reduce hands-on time and produce accurate and trusted results. Support and customer care are provided through in-house experts. Founded in 2004 and based in Stockholm, Sweden, Devyser provides genetic tests to diagnostic laboratories in over 60 countries worldwide, both through its distributor network and directly to laboratories.